Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) FCF Payout Ratio (2021 - 2025)

Ani Pharmaceuticals' FCF Payout Ratio history spans 5 years, with the latest figure at 0.01 for Q3 2025.

  • For Q3 2025, FCF Payout Ratio fell 44.31% year-over-year to 0.01; the TTM value through Dec 2025 reached 0.01, down 75.46%, while the annual FY2025 figure was 0.01, 75.46% down from the prior year.
  • FCF Payout Ratio for Q3 2025 was 0.01 at Ani Pharmaceuticals, up from 0.01 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 0.35 in Q3 2022 and bottomed at 0.05 in Q4 2022.
  • The 5-year median for FCF Payout Ratio is 0.01 (2025), against an average of 0.03.
  • The largest annual shift saw FCF Payout Ratio crashed 249.79% in 2022 before it surged 209.79% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.02 in 2021, then crashed by 249.79% to 0.05 in 2022, then surged by 117.71% to 0.01 in 2023, then soared by 165.95% to 0.03 in 2024, then plummeted by 57.4% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for ANIP's FCF Payout Ratio are 0.01 (Q3 2025), 0.01 (Q2 2025), and 0.01 (Q1 2025).